FHA
NDRA icon

Flagship Harbor Advisors’s ENDRA Life Sciences NDRA Stock Holding History

Flagship Harbor Advisors’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20
Closed -$1.81M – 665
2021
Q1 		$1.81M Buy
+20
New +$1.5M 0.21% 115

Other funds holding NDRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
5L
55I LLC Boston, Massachusetts $3.58B AUM 17.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Flagship Harbor Advisors's NDRA Position: Q2 2021 in Review

Flagship Harbor Advisors sold out of ENDRA Life Sciences (NDRA) in Q2 2021, closing a stake of 20 shares — an estimated $1.81M sold.

Flagship Harbor Advisors first reported a position in NDRA in Q1 2021 and held it in 1 quarter. The position peaked at $1.81M in Q1 2021. 14 funds tracked by Wall St. Rank hold NDRA as of Q2 2021.

  • Flagship Harbor Advisors reported no remaining ENDRA Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Flagship Harbor Advisors sold 20 ENDRA Life Sciences shares in Q2 2021, an estimated $1.81M.
  • Flagship Harbor Advisors first reported a position in ENDRA Life Sciences in Q1 2021 and held it in 1 quarter.
  • Flagship Harbor Advisors's ENDRA Life Sciences position peaked at $1.81M in Q1 2021.
  • 14 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2021.

Based on Flagship Harbor Advisors's 13F filing for Q2 2021, filed 26 Jul 2021.